Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer
Release Date:
Interview with Gretchen L. Gierach, PhD, author of Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting
Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer